Literature DB >> 10982614

Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.

S Masuhara1, K Kasuya, T Aoki, A Yoshimatsu, A Tsuchida, Y Koyanagi.   

Abstract

It is well known that the incidence of biliary cancer is higher in patients with pancreaticobiliary maljunction (PBM) than in individuals without PBM. However, the relationship between PBM and the carcinogenesis remains unclear. The purpose of the present study was to examine histopathologic changes in the mucosa of the gallbladder and bile duct in patients with PBM, and to investigate K-ras oncogene mutation and overexpression of p53 protein in the mucosa. We examined 47 surgical specimens of gallbladder and 36 surgical specimens of bile duct obtained from 48 patients with PBM. The 48 patients were divided into three age groups: group A (0-3 years), group B (4-39 years), and group C (40 years or more). Investigation of K-ras mutation and overexpression of p53 protein was performed using an enriched polymerase chain reaction (PCR) and enzyme-linked mini-sequence assay (ELMA), and by the streptavidin-biotin (SAB) method, using DO-7 antibodies, respectively. Hyperplastic changes in the gallbladder mucosa were observed in patients in the three groups. However, metaplastic or dysplastic changes were observed in the mucosa of only groups B and C. K-ras gene mutation in the gallbladder mucosa was found in 18.8% of the hyperplastic mucosae in group B and in 20% in group C. The mutation was found in 33.3% of lesions with metaplastic change associated with hyperplastic changes and in 25% of lesions with dysplastic changes in group C. No mutation was observed in the non-cancerous mucosae of gallbladders and bile ducts without congenital dilatation of the bile duct. Overexpression of p53 protein was observed only in carcinoma of the gallbladder; in seven of nine advanced carcinomas and in two of three carcinomas in situ. We concluded that the mucosal epithelia of the biliary system in patients with PBM showed a high frequency of gene mutations and the carcinogenesis appeared in involve a multistage process of mutation in the K-ras gene and the p53 suppressor gene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982614     DOI: 10.1007/s005340050176

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  13 in total

1.  Carcinogenesis and chemoprevention of biliary tract cancer in pancreaticobiliary maljunction.

Authors:  Akihiko Tsuchida; Takao Itoi
Journal:  World J Gastrointest Oncol       Date:  2010-03-15

2.  Histological study of gallbladder and bile duct epithelia in patients with anomalous arrangement of the pancreaticobiliary ductal system: comparison between those with and without a dilated common bile duct.

Authors:  Yutaka Noda; Naotaka Fujita; Go Kobayashi; Kei Ito; Jun Horaguchi; Osamu Takasawa; Takashi Obana; Kazuhiko Ishida; Shigeharu Senoo; Makoto Yonechi; Takashi Suzuki; Dai Hirasawa; Toshiki Sugawara; Masao Kobari; Takashi Sawai; Miwa Uzuki; Mika Watanabe
Journal:  J Gastroenterol       Date:  2007-03-30       Impact factor: 7.527

Review 3.  Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates.

Authors:  Tarun Rustagi; Constantin A Dasanu
Journal:  J Gastrointest Cancer       Date:  2012-06

4.  Precancerous Pyloric Gland Metaplasia in the Biliary Epithelium Associated with Congenital Biliary Dilatation in a Three-Month-Old Infant.

Authors:  Shuichi Takano; Toshimichi Hasegawa; Kohga Masuda; Takehiko Hanaki; Naruo Tokuyasu; Teruhisa Sakamoto; Kanae Nosaka; Yoshiyuki Fujiwara
Journal:  Yonago Acta Med       Date:  2022-01-21       Impact factor: 1.641

5.  miR-125b suppresses cellular proliferation by targeting c-FLIP in gallbladder carcinoma.

Authors:  Huajie Zong; Huading Zhou; Yang Xiang; Gang Wu
Journal:  Oncol Lett       Date:  2019-10-18       Impact factor: 2.967

Review 6.  Molecular Oncology of Gall Bladder Cancer.

Authors:  Arun Chaturvedi; Vijay Kumar; Sameer Gupta
Journal:  Indian J Surg Oncol       Date:  2019-11-16

7.  Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582.

Authors:  Amita Chaube; Mallika Tewari; R S Garbyal; Usha Singh; Hari S Shukla
Journal:  BMC Cancer       Date:  2006-05-10       Impact factor: 4.430

8.  Pancreaticobiliary maljunction is associated with common bile duct carcinoma: a meta-analysis.

Authors:  Yang Li; Jun Wei; Zhongxin Zhao; Tiangeng You; Mingan Zhong
Journal:  ScientificWorldJournal       Date:  2013-12-30

9.  Carcinoma of the Papilla of Vater after Diversion Operation for Pancreaticobiliary Maljunction.

Authors:  Takahiro Yamanaka; Kenichiro Araki; Norihiro Ishii; Mariko Tsukagoshi; Takamichi Igarashi; Akira Watanabe; Norio Kubo; Hiroyuki Kuwano; Ken Shirabe
Journal:  Case Rep Gastroenterol       Date:  2017-05-17

Review 10.  Risk factors for biliary tract and ampullary carcinomas and prophylactic surgery for these factors.

Authors:  Masaru Miyazaki; Tadahiro Takada; Shuichi Miyakawa; Kazuhiro Tsukada; Masato Nagino; Satoshi Kondo; Junji Furuse; Hiroya Saito; Toshio Tsuyuguchi; Kazuo Chijiiwa; Fumio Kimura; Hideyuki Yoshitomi; Satoshi Nozawa; Masahiro Yoshida; Keita Wada; Hodaka Amano; Fumihiko Miura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.